Mark A. Lemmon facts for kids
Quick facts for kids
Mark Lemmon
|
|
|---|---|
.jpg)
Lemmon in 2016
|
|
| Born | 1964 (age 61–62) Norfolk, England
|
| Education | Norwich School |
| Alma mater | |
| Spouse(s) | Katherine Ferguson |
| Scientific career | |
| Fields |
|
| Institutions | |
| Thesis | Specific interactions between transmembrane alpha-helices: Their role in the oligomerisation of integral membrane proteins (1993) |
| Doctoral advisor | Donald Engelman |
Mark Lemmon is a famous scientist from England. He is a biochemist, which means he studies the chemistry of living things. He works at Yale University as a professor and leads the Department of Pharmacology. He also helps run the Cancer Biology Institute there, where they study how to fight cancer.
Contents
Early Life and Education
Mark Lemmon was born in Norfolk, England, in 1964. He grew up in the towns of Taverham and Poringland. He attended Norwich School from 1976 to 1983.
After school, he went to Hertford College, Oxford, a part of the University of Oxford. In 1988, he earned a top degree in biochemistry. Later, he continued his studies at Yale University. There, he completed his PhD, focusing on how certain parts of proteins, called alpha-helices, work together.
Research and Career Highlights
After finishing his PhD, Mark Lemmon worked as a researcher at New York University. He then joined the University of Pennsylvania in 1998. He became a full professor there in 2001 and led a department starting in 2008. In 2015, he moved to Yale University.
Understanding Cell Signals
Dr. Lemmon's research combines different science fields. He uses biochemistry and structural biology to understand how cells communicate. He focuses on special "receivers" on cell surfaces called growth factor receptors. These receptors are like antennas that pick up signals, telling cells what to do.
He has studied important receptors like the epidermal growth factor (EGF) receptor. His work helps us understand how these signals control cell growth and behavior. He also helped figure out how a part of proteins called the Pleckstrin homology domain works.
Fighting Cancer with Science
A big part of Dr. Lemmon's work is about cancer. He studies how growth factor receptors can sometimes go wrong. When they don't work correctly, they can cause cells to grow out of control, leading to cancer.
His research helps scientists find new ways to stop cancer. By understanding how these receptors work, doctors can develop better medicines. These medicines can target the faulty signals in cancer cells. Dr. Lemmon's recent work focuses on using this knowledge to make cancer treatments more effective.
Leadership and Contributions
Before joining Yale, Dr. Lemmon was a professor and department chair at the Perelman School of Medicine at the University of Pennsylvania. His research has received funding from important organizations like the National Cancer Institute.
He also helps guide the scientific community. He serves on the editorial boards of several major science journals, including Cell and Molecular Cell. This means he helps decide which new research gets published. He also served as a leader for the American Society for Biochemistry and Molecular Biology (ASBMB).
Awards and Recognition
Mark Lemmon has received several important awards for his scientific work.
- In 2016, he was chosen as a Fellow of the Royal Society (FRS). This is a very high honor for scientists in the United Kingdom.
- In 2023, he became an ASBMB Fellow.
- In 2024, he was named a Member of the Connecticut Academy of Science and Engineering (CASE).
- In 2012, he received the Dorothy Hodgkin prize from the Protein Society.
